Renal denervation achieves sustained blood pressure reduction, finds trial

Endovascular ultrasound renal denervation, a one-off procedure targeting the nerves in the renal arteries, maintains lower blood pressure (BP) in patients with moderate hypertension at six months compared with patients given a sham procedure, a randomised trial has shown.1

“If long term safety and efficacy is proven in larger trials that are currently underway, we hope that renal denervation therapy could soon be offered as an alternative to many lifelong drugs for hypertension,” said the principal investigator in the UK, Melvin Lobo from Queen Mary University of London …